PortfoliosLab logoPortfoliosLab logo
OPAD vs. VOR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OPAD vs. VOR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Offerpad Solutions Inc. (OPAD) and Vor Biopharma Inc. (VOR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OPAD achieves a -68.02% return, which is significantly lower than VOR's 61.70% return.


OPAD

1D
-6.75%
1M
-26.84%
6M
-62.06%
YTD
-68.02%
1Y
-68.28%
3Y*
-68.01%
5Y*
-69.56%
10Y*
ALL TIME*
-65.84%

VOR

1D
-2.98%
1M
2.72%
6M
62.69%
YTD
61.70%
1Y
-49.64%
3Y*
-30.65%
5Y*
-39.00%
10Y*
ALL TIME*
-48.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$176.09K$234.55K$395.69K
$17.33M$24.46M$20.23M

OPAD vs. VOR - Yearly Performance Comparison


2026 (YTD)20252024202320222021
OPAD
Offerpad Solutions Inc.
-68.02%-57.54%-72.20%48.39%-92.80%-43.76%
VOR
Vor Biopharma Inc.
61.70%-41.08%-50.67%-66.17%-42.77%-72.35%

Correlation

The correlation between OPAD and VOR is 0.15, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.15

Correlation (3Y)
Balances recent behavior with more history.

0.12

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.16

Correlation (All Time)
Calculated using the full available price history since Feb 5, 2021

0.15

Fundamentals

Market Cap

OPAD:

$11.99M

VOR:

$1.15B

EPS

OPAD:

-$1.08

VOR:

-$44.48

Total Revenue (TTM)

OPAD:

$487.19M

VOR:

$0.00

Gross Profit (TTM)

OPAD:

$37.09M

VOR:

-$23.00K

EBITDA (TTM)

OPAD:

-$29.30M

VOR:

-$1.13B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OPAD vs. VOR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

OPAD
OPAD Risk / Return Rank: 3030
Overall Rank
OPAD Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
OPAD Sortino Ratio Rank: 4141
Sortino Ratio Rank
OPAD Omega Ratio Rank: 3939
Omega Ratio Rank
OPAD Calmar Ratio Rank: 1616
Calmar Ratio Rank
OPAD Martin Ratio Rank: 2525
Martin Ratio Rank

VOR
VOR Risk / Return Rank: 2929
Overall Rank
VOR Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
VOR Sortino Ratio Rank: 3434
Sortino Ratio Rank
VOR Omega Ratio Rank: 3434
Omega Ratio Rank
VOR Calmar Ratio Rank: 2323
Calmar Ratio Rank
VOR Martin Ratio Rank: 2929
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

OPAD vs. VOR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Offerpad Solutions Inc. (OPAD) and Vor Biopharma Inc. (VOR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


OPADVORDifference
Sharpe ratioReturn per unit of total volatility

+0.08

Sortino ratioReturn per unit of downside risk

+0.25

Omega ratioGain probability vs. loss probability

1.03

1.01

+0.03

Calmar ratioReturn relative to maximum drawdown

-0.74

-0.57

-0.16

Martin ratioReturn relative to average drawdown

-0.92

-0.79

-0.13

OPAD vs. VOR - Sharpe Ratio Comparison

The current OPAD Sharpe Ratio is -0.35, which is comparable to the VOR Sharpe Ratio of -0.42. The chart below compares the historical Sharpe Ratios of OPAD and VOR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

OPAD vs. VOR - Drawdown Comparison

The maximum OPAD drawdown since its inception was -99.87%, roughly equal to the maximum VOR drawdown of -99.72%. Use the drawdown chart below to compare losses from any high point for OPAD and VOR.


Loading charts...

Drawdown Indicators


OPADVORDifference

Max Drawdown

Largest peak-to-trough decline

-99.87%

-99.72%

-0.15%

Max Drawdown (1Y)

Largest decline over 1 year

-93.79%

-85.92%

-7.87%

Max Drawdown (3Y)

Largest decline over 3 years

-97.03%

-94.85%

-2.18%

Max Drawdown (5Y)

Largest decline over 5 years

-99.87%

-99.16%

-0.71%

Current Drawdown

Current decline from peak

-99.87%

-98.04%

-1.83%

Average Drawdown

Average peak-to-trough decline

-82.51%

-88.92%

+6.41%

Ulcer Index

Depth and duration of drawdowns from previous peaks

74.79%

61.89%

+12.90%

Volatility

OPAD vs. VOR - Volatility Comparison

Offerpad Solutions Inc. (OPAD) and Vor Biopharma Inc. (VOR) have volatilities of 26.05% and 24.91%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OPADVORDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.05%

24.91%

+1.14%

Volatility (6M)

Calculated over the trailing 6-month period

62.05%

57.54%

+4.51%

Volatility (1Y)

Calculated over the trailing 1-year period

198.91%

116.05%

+82.86%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

132.10%

116.61%

+15.49%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

124.62%

116.15%

+8.47%

Dividends

OPAD vs. VOR - Dividend Comparison

Neither OPAD nor VOR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

OPAD vs. VOR - Financials Comparison

This section allows you to compare key financial metrics between Offerpad Solutions Inc. and Vor Biopharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


OPAD and VOR have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OPAD has higher volatility (26.05%) compared to VOR (24.91%). In terms of maximum drawdown, OPAD dropped -99.87% vs VOR's -99.72%.

OPAD currently has the higher Sharpe Ratio (-0.35 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OPAD and VOR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer